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Objectives We sought to determine whether the type of shunt used at stage one palliation (S1P) affected the survival and
the perioperative course through Fontan completion.
Background Although improved surgical and interstage survival have been demonstrated with the use of the right ventricle to
pulmonary artery (RV-PA) conduit compared with a modified Blalock-Taussig shunt (BTS) at S1P, it is unknown
whether this effect will be observed in long-term follow-up.
Methods All patients who underwent a S1P during 2002 and 2003 (n  80) at our institution were included for analysis.
Patients were followed until death or June 1, 2007. Perioperative variables at Fontan completion were recorded.
Results For the entire cohort, cumulative survival for those who underwent a RV-PA conduit (n  34) was 79.4% at 3
years compared with 65.8% in the modified BTS group (n  46) (log-rank  0.31). At Fontan (n  44), when
compared with those who had received a modified BTS, those who had a RV-PA conduit placed at S1P had no
difference in the median duration of ventilation (21 h [range 10 to 96 h] vs. 26.5 h [range 7 to 204 h], p 
0.09) or hospital stay (9 days [range 5 to 29 days] vs. 10 days [range 6 to 48 days], p  0.89), although length
of stay in the intensive care unit was shorter (2 days [range 0 to 6 days] vs. 4 days [range 1 to 25 days], p 
0.01). Sixty-seven percent of the RV-PA conduit group had at least one PA intervention 3 years after S1P com-
pared with 42.8% in the modified BTS group (log-rank  0.11).
Conclusions Nonstatistically significant trends toward improved cumulative survival and increased PA interventions were
demonstrated in patients who had a RV-PA conduit placed at S1P. Longitudinal follow-up of larger groups of ran-
domized patients is required to determine the influence of the RV-PA conduit on long-term outcomes. (J Am
Coll Cardiol 2008;52:52–9) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.03.034S
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ffter the initial description of the technique by Norwood
t al. (1,2), the use of a right ventricle to pulmonary artery
RV-PA) conduit as the source of pulmonary blood flow at
tage one palliation (S1P) for hypoplastic left heart syn-
rome (HLHS) has recently been pioneered by Sano et al.
3,4). In some series, the use of the RV-PA conduit at
rom the Departments of *Cardiology and †Cardiac Surgery, Children’s Hospital,
nd the Departments of ‡Pediatrics and §Surgery, Harvard Medical School, Boston,
assachusetts; Pediatric and Congenital Cardiac Surgery Unit, Centro Gallucci,
niversity of Padua Medical School, Padua, Italy; and the ¶Children’s National
edical Center, Washington, DC.b
Manuscript received July 27, 2007; revised manuscript received February 27, 2008,
ccepted March 11, 2008.1P has been associated with improved surgical and
nterstage mortality when compared with the use of a
odified Blalock-Taussig shunt (BTS) (5–7). Improved
oronary and splanchnic flow resulting from increased
ost-operative diastolic pressure in the RV-PA conduit
roup could be an explanation for this observed improved
hort-term survival. Studies evaluating survival through
nd after bidirectional cavopulmonary anastomosis
BCPA) after an RV-PA conduit are limited. A require-
ent for earlier palliation with a BCPA, largely attrib-
ted to an earlier onset of significant cyanosis, has been
eported (8). In at least one report, the type of shunt used
or pulmonary blood flow had no demonstrated survival
enefit through stage two palliation (9,10).
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July 1, 2008:52–9 Fontan Outcomes After mBTS or RV to PA ConduitBecause of the necessity of a ventriculotomy with a
V-PA conduit and the ensuing potential for late develop-
ent of ventricular dysfunction, aneurysms and/or arrhyth-
ias, it is unknown whether the early survival benefit will
ontinue through mid- and long-term follow-up (11–14).
learly, at BCPA completion, the immediate impacts of the
V-PA conduit to diastolic blood flow to distal organ beds,
rowth of pulmonary arteries, and alterations in ventricular
olume loading have been removed. Reports of impaired
rowth and increased need for intervention on the
ulmonary arteries with RV-PA conduit through follow-up
ave raised further concerns (15).
To date, there is no published comparison of periopera-
ive course or survival through Fontan completion of 2
ohorts of patients undergoing each technique, during the
ame era at the same institution. In this study, we retro-
pectively analyzed a cohort of 80 patients who contempo-
aneously underwent either the RV-PA conduit or modified
TS during S1P for single ventricle defects at our institu-
ion and who are now of the age for consideration for
ontan completion. We under took this study 1) to examine
hether the clinical course and perioperative outcomes
iffer between the 2 groups at Fontan completion; 2) to
efine the rate of pulmonary artery interventions for the 2
roups beginning at stage one palliation through Fontan
ompletion; and, finally, 3) to determine the impact of the
V-PA conduit on survival on the entire cohort through the
sual period of Fontan completion.
ethods
tudy design. The study design is a retrospective case
eries including all patients who underwent a S1P at our
nstitution from January 1, 2002, through December 31,
003. The Committee for Clinical Research at Children’s
ospital Boston, Boston, Massachusetts, approved the
eview of patient records for this study. During the study
eriod, 2 approaches to surgical S1P were used at our
nstitution: one that used a modified BTS and one that used
RV-PA conduit. The choice of operative approach at S1P
as at the discretion of the patient’s surgeon and cardiolo-
ist (16).
Patients were grouped by the type of shunt used at S1P (a
odified BTS or a RV-PA conduit). The early S1P
erioperative, interstage and perioperative courses, and out-
omes after BCPA surgery from this cohort of patients have
een previously described (9,16). Our institutional practice
or final palliation of patients with single ventricle lesions
ypically involves a complete echocardiogram and hemody-
amic catheterization at 18 to 24 months of age followed by
Fontan operation at 24 to 30 months. In this study, only
atients who underwent Fontan completion at our institu-
ion were included in the description of perioperative
ontan course.
All patients were followed until death, loss to follow-up,r June 1, 2007. It was recorded whether patients had died, bnderwent Fontan completion,
ere converted to, or were in the
rocess of being converted to a
iventricular circulation. Demo-
raphic and anatomical data were
eviewed for all patients. For the
urpose of multivariable hazard
esting, relevant S1P periopera-
ive variables were also reviewed
or all patients.
For those who underwent a
ontan procedure at our institu-
ion, the last complete echocar-
iogram and catheterization be-
ore the procedure were included for analysis. All
atheterization and operative reports from the time of stage
ne palliation (S1P) through June 1, 2007, were reviewed to
etermine the number and type of interventions on the
ulmonary arteries. Both surgical patch plasty and/or
atheter-based balloon dilation, with or without stent place-
ent, were recorded for all patients undergoing Fontan
hrough the follow-up period.
The type of Fontan procedure performed, the length of
ardiopulmonary bypass time, and the need for additional
perative procedures, including atrial septectomy, pulmo-
ary artery plasty, arch augmentation or coarctation repair,
r tricuspid valvuloplasty, were recorded. Indicators of
linical course at the time of Fontan, including the length of
echanical ventilation, duration of indwelling chest tubes
nd amount of chest tube output in the first 48 h after
urgery, and the lengths of intensive care unit and hospital
tay, were recorded. By reviewing the first 48 h after surgery,
e were able to calculate, by the formula modified from
ernovsky et al. (17), a peak inotrope score.
tatistical analysis. Measures of central tendency and dis-
ersion are expressed in terms of median and range as a
esult of the observed skewness in the distributions of
redictor variables. Bivariable associations between demo-
raphic, anatomic, and clinical variables and operative group
ere assessed with the Wilcoxon rank-sum test and chi-
quare or Fisher exact tests for continuous and categorical
ariables, respectively. Cumulative survival functions were
onstructed with Kaplan-Meier estimates and event times
ompared between subgroups with the use of log-rank tests.
ox proportional hazards survival modeling was used to
dentify independent risk factors for death for the entire
ohort.
The number of hazard regression model covariates is
imited by the total number of events (deaths) (18,19).
iven the number of events in the present analysis (n 22),
e considered for inclusion in the model only those peri-
perative variables found to be significant in univariate
nalyses (p  0.05), the principle variable of interest (S1P
perative group), and a previously reported strong risk factor
or surgical death, the presence of an intact atrial septum at
Abbreviations
and Acronyms
BCPA  bidirectional
cavopulmonary
anastomosis
BTS  Blalock-Taussig
shunt
HLHS  hypoplastic left
heart syndrome
RV-PA  right ventricle to
pulmonary artery
S1P  stage one palliationirth (20,21). Both the proportional hazards assumption
a
a
r
c
S
S
S
m
R
P
t
b
s
(
p
d
t
p
r
r
t
i
i
S
s
n
p
m
m
0
d
i
c
B
d
c
p
p
(
m
e
S
F
i
m
p
g
R
2
B
S
R
p
P
i
54 Scheurer et al. JACC Vol. 52, No. 1, 2008
Fontan Outcomes After mBTS or RV to PA Conduit July 1, 2008:52–9nd the functional form of continuous model variables were
ssessed based on cumulative sums of martingale-based
esiduals (22).
All statistical tests were 2-sided, and type I error was
ontrolled at level 0.05. Analyses were performed using
AS (Version 9.1, SAS Institute, Cary, North Carolina),
PSS (Version 14.0, SPSS Inc., Chicago, Illinois), and
igmaplot (Version 10.0, Systat Software, Inc., Rich-
ond, California).
esults
atient outcomes. During the follow-up period, 22 pa-
ients died. In the modified BTS group (n  46), 5 died
efore discharge after S1P and 6 died during the inter-
tage period before BCPA as has been previously described
Fig. 1) (9,16). In the RV-PA conduit group (n  34), 5
atients died before discharge after S1P and no patients
ied in the interstage period before BCPA (9,16). Among
hose 6 patients with a BTS who died in the interstage
eriod before BCPA, 5 were followed after S1P by the
eferral institution. Compared with those patients who
esided in the U.S., underwent a BTS, and returned to have
he BCPA at our institution (n  27), those who suffered
nterstage death before BCPA demonstrated trends toward
ncreased distance between primary residence and site of
1P (47.5 miles [3.45 to 1,225.9 miles] for interstage
urvivors vs. 724 miles [28.7 to 1,102.1 miles] for interstage
onsurvivors, p  0.07) and increased distance between
rimary residence and site of interstage follow-up (18.7
n = 5 n = 0
n = 2
Alive at follow-up
n = 23
Fontan at CHB
n = 23
Alive
Fo
BC
  S1P 
n
Death prior to D/C
n = 5
Interstage Death
n = 6
Interstage Death
n = 2
Death prior to D/C
n = 1
Dead at follow-up
n = 1
Alive a
Fontan at CHB
n = 26
BCPA at CHB
n = 27
S1P
n
Figure 1 Outcome of 80 Patients Who Underwent S1P From 20
A tree of outcomes is presented for both RV-PA and BTS. *p  0.74 between 2 gr
1.0 between 2 groups (Fisher exact test). BCPA  bidirectional cavopulmonary ana
D/C  discharge; OSH  outside hospital; RV-PA  right ventricle to pulmonary ailes [1.7 to 207.5 miles] for interstage survivors vs. 72.1
iles [3.4 to 178.9 miles] for interstage nonsurvivors, p 
.12). No patient in either operative group died before
ischarge after BCPA. Two in each group died in the
nterstage period before Fontan. No patient in the RV-PA
onduit group died after Fontan, whereas in the modified
TS group, 1 died before discharge after Fontan and one
ied in the follow-up period 12.5 months after Fontan
ompletion. For all patients during the entire follow-up
eriod, there was no association between distance between
lace of primary residence and site of S1P and survival
391.3 miles [1.43 to 2,585.25 miles] for survivors vs. 266.8
iles [0 to 1,102.1 miles] for nonsurvivors, p  0.66).
Four patients in the RV-PA group were cannulated for
xtracorporeal membrane oxygenation in the post-operative
1P period versus 4 in the modified BTS group (p  0.54).
orty-nine patients underwent Fontan completion at our
nstitution (23 in the RV-PA conduit group vs. 26 in the
odified BTS group), whereas 6 underwent Fontan com-
letion at another institution (1 in the RV-PA conduit
roup vs. 5 in the modified BTS group). Two patients in the
V-PA conduit group underwent conversion to a
-ventricle circulation after BCPA, whereas in the modified
TS group 3 patients underwent a 2-ventricle repair after
1P and 1 patient after the Fontan procedure. In the
V-PA conduit group, 1 patient is awaiting Fontan com-
letion (Fig. 1).
re-Fontan characteristics. Twenty-six patients of the
nitial 46 (56.5%) who had a modified BTS during their
w-up
OSH Pending Fontan
n =1
Alive at follow-up
n = 2
2V repair
n = 2
HB
-PA
-up
Alive at follow-up
n = 1
2V repair
n = 1
Alive at follow-up
n = 5
Fontan at OSH
n = 5
BCPA at OSH
n = 5
Alive at follow-up
n = 3
2V repair
n = 3
TS
hrough 2003
(Fisher exact test), †p  0.04 between 2 groups (Fisher exact test), and ‡p 
sis; BTS  modified Blalock-Taussig shunt; CHB  Children’s Hospital Boston;
hunt; S1P  stage one palliation; 2V repair  biventricular repair. at follo
n = 1
ntan at 
n = 1
PA at C
n = 29
+ RV
 = 34
t follow
n = 23
 + B
 = 46
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July 1, 2008:52–9 Fontan Outcomes After mBTS or RV to PA Conduitnitial S1P have subsequently undergone Fontan completion
t our institution, compared with 23 of 34 (67.6%) of those
ho underwent a RV-PA (p  0.44). There were no
ifferences between the 2 groups in the age or weight at
ontan completion, gender, the presence of morphology
ther than HLHS, or subtype of HLHS morphology
Table 1). There were no differences between the groups in
re-operative grades of echocardiographically assessed sys-
emic atrioventricular valve regurgitation, neoaortic regur-
itation, or ventricular dysfunction. Similarly, no differences
ere observed in cardiac index, systemic ventricular end-
iastolic pressure, mean pulmonary artery pressure, pulmo-
emographics and Cardiacorphology of Patients Undergoing Fontan
Table 1 Demographics and CardiacMorphology of Patients Undergoing Fontan
BTS
(n  26)
RV-PA Conduit
(n  23) p Value
Demographics
Age at Fontan (yrs) 2.3 (1.4–5.3) 2.6 (1.6–4.3) 0.11
Weight (kg) 11.6 (8.4–16.3) 11.3 (8.8–16.3) 0.89
BSA (kg/m2) 0.52 (0.42–0.62) 0.51 (0.42–0.66) 0.84
Gender, male 14/26 (54%) 12/23 (52%) 0.91
Morphology
HLHS type
MA/AA 4/26 (15%) 7/23 (30%) 0.31*
MS/AA 7/26 (27%) 3/23 (13%) 0.30*
MA/AS 0/26 (0%) 1/23 (4%) 0.47*
MS/AS 11/26 (42%) 10/23 (43%) 0.93
Non-HLHS
DORV-MA 3/26 (12%) 1/23 (4%) 0.62*
Shone’s syndrome 1/26 (4%) 0/23 (0%) 1.0*
DILV 0/26 (0%) 1/23 (4%) 1.0*
alues are median (range) or frequency (column percent) for continuous and categorical variables,
espectively. p values were obtained from Wilcoxon rank-sum test (continuous variables) and
hi-square test (categorical variables), except where noted. *Fisher exact test.
AA aortic atresia; AS aortic stenosis; BSA body surface area; BTS Blalock-Taussig shunt;
ILV  double inlet left ventricle; DORV  double outlet right ventricle; HLHS  hypoplastic left
eart syndrome; MA  mitral atresia; MS  mitral stenosis; RV-PA  right ventricle to pulmonary
rtery.
chocardiographic and Catheterization Variables Before Fontan
Table 2 Echocardiographic and Catheterization Variables Befor
BTS
Total No.
Echocardiography
AVV regurgitation, 0 (none) to 4 (severe) 26
Neoaortic regurgitation, 0 (none) to 4 (severe) 26
SV dysfunction, 0 (none) to 4 (severe) 26
Aortic arch obstruction, 0 (none) to 4 (severe) 26
Catheterization
Cardiac index (l/min/m2) 25
SVedp (mm Hg) 25
Mean PAp 26
Rp (U/m2) 24
Atrial pressure (mm Hg) 25
Qp:Qs 22
alues are median (range) or frequency (column percent) for continuous and categorical variables
or trend (ordinal variables).
AVV  atrioventricular valve; BTS  Blalock-Taussig shunt; PAp  pulmonary artery pressure; Qp:Qs 
o pulmonary artery; SV  single ventricle; SVedp  single ventricle end-diastolic pressure.ary vascular resistance, common atrial pressure, or ratio of
ulmonary to systemic blood flow the at pre-operative
atheterization (Table 2). There were no differences be-
ween the 2 groups during these catheterizations in the
umbers of aortopulmonary collaterals coiled (0 [0 to 3] in
he RV-PA shunt group vs. 0 [0 to 7] in the modified BTS
roup, p  0.69) or in the number of patients who
nderwent balloon dilations of residual aortic coarctation (3
13%] in the RV-PA shunt group vs. 7 [26.9%] in the
odified BTS group, p  0.24).
ulmonary artery and other interventions since S1P.
lthough there was a trend toward increasing number of
atients in the RV-PA shunt group who had Fontan
ompletion with at least one intervention on the pulmonary
rteries since S1P at 5 years of follow-up, either surgical
atch plasty or catheter balloon dilation with or without a
tent, this did not reach statistical significance (15 [65.2%]
n the RV-PA shunt group vs. 12 [46.2%] in the modified
TS group, log-rank  0.09) (Fig. 2).
ontan operative course. Forty-seven patients underwent
lateral tunnel Fontan procedure, and 2 patients had an
xtracardiac conduit Fontan. A fenestration allowing shunt-
ng of blood from the venous baffle to the left atrium was
reated for all patients. All previous BCPA palliations were
idirectional Glenn procedures.
Total bypass time for Fontan completion was similar
etween the 2 groups. Although Fontan completion in
atients in the RV-PA conduit group involved an increased
se of aortic-cross clamps (20/23 vs. 11/24; p  0.01),
he duration of cross-clamp use was similar between
roups of those exposed to it (53.5 min [13 to 77 min] for
he RV-PA group vs. 46 min [33 to 107 min] p  0.89)
Table 3). In cases in which no aortic cross-clamp was
sed, induced fibrillation of the heart during hypothermic
ardiopulmonary bypass was used. The use of circulatory
tan
RV-PA Conduit
p Valuealue Total No. Value
(0–4) 23 2 (0–3) 0.09
(0–4) 23 0 (0–2) 0.63
(0–4) 23 1 (0–3.5) 0.18
(0–2) 23 0 (0–2) 0.39
(2–4.4) 18 3.4 (2–6.1) 0.30
(4–19) 22 8.5 (3–18) 0.26
(9–24) 22 12.5 (9–18) 0.27
(0.9–4) 18 1.8 (0.5–4) 0.69
(6–16) 22 8.5 (4–12) 0.13
(0.5–1.8) 15 0.65 (0.42–1.0) 0.45
tively. p values were obtained from Wilcoxon rank-sum test (continuous variables), Armitage teste Fon
V
2
0.5
0
0
3.2
10
12.5
1.7
10
0.68
, respecratio of pulmonary to systemic flow; Rp  pulmonary vascular resistance; RV-PA  right ventricle
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Fontan Outcomes After mBTS or RV to PA Conduit July 1, 2008:52–9rrest was limited to one patient in the modified BTS
roup.
The number of patients who received at least 1 additional
perative procedure at the time of Fontan was similar as well
etween the groups (12 [52.2%] in the RV-PA group vs. 12
46.2%], p  0.67). Seven patients underwent tricuspid
alvuloplasty at the time of Fontan, 3 in the RV-PA conduit
roup and 4 in the modified BTS group. One patient in the
V-PA conduit group underwent transverse arch augmen-
ation, whereas one patient in each group underwent en-
argement of the atrial septal defect. One patient underwent
he placement of a dual-chamber pacing system in the
Figure 2 Kaplan-Meier Plot of Survival After
S1P by Type of Pulmonary Arterial Shunt
Freedom from pulmonary artery intervention
after S1P is shown. Abbreviations as in Figure 1.
Operative and Post-Operative Courses at Fontan
Table 3 Operative and Post-Operative Cours
BTS (n 
Operative variables
TBT (min) 107.5 (63–1
Use of aortic cross-clamp 11 (42%)
Aortic cross-clamp time (min) 46 (33–1
Use of circulatory arrest 1 (4%)
Additional operative procedures
Tricuspid valvuloplasty 4 (15.3%
Atrial septum resection 1 (4%)
Aortic arch augmentation 0 (0%)
PA patch augmentation 8 (30.7%
Postoperative course
Peak inotrope score 10 (5–22
CT output first 48 h (ml/kg/day) 35.5 (14–1
Duration of indwelling CT (days) 6.5 (2–31
Duration of ventilation (h) 26.5 (7–20
Length of ICU stay (days) 4 (1–25
Length of hospital stay (days) 10 (6–48
Values are median (range) and frequency (column percent) for conti
Wilcoxon rank-sum test (continuous variables) and chi-square or FisheBTS  Blalock-Taussig shunt; CPB  cardiopulmonary bypass; CT  chest t
ventricle to pulmonary artery; TBT  total bypass time;odified BTS group, whereas one patient had epicardial
eads placed in the RV-PA conduit group. A similar number
nderwent pulmonary artery patch augmentation at the
ime of Fontan (6 [26.1%] in the RV-PA conduit group vs.
[30.7%], p  0.72) (Table 3).
ontan post-operative course. The post-operative course
or patients in both groups was similar. There were no
ifferences observed in the peak inotrope score in the first 48
ost-operative hours. The amount of chest tube drainage
as similar between the 2 groups in the first 48 post-
perative hours, as was the total duration of indwelling chest
ubes. The difference in total duration of mechanical ven-
ilation between the groups approached statistical signifi-
ance (21 h [10 to 96 h] in the RV-PA group vs. 26.5 h [7
o 204 h], p 0.09). There was a shorter length of intensive
are stay in the RV-PA conduit group (2 days [0 to 6 days]
s. 4 days [1 to 25 days], p  0.01); however, the total
ospital length of stay was similar between the groups (9
ays [5 to 29 days] vs. 10 days [6 to 48 days], p  0.89)
Table 3).
urvival. Cumulative survival for the entire cohort of 80
atients was 78.7% at 1 year and 71.4% at 3 years. For the
atients who underwent a RV-PA conduit during S1P (n
4), survival at 1 year was 82.4% and 79.4% at 3 years
ompared with 75.9% at 1 year and 65.8% at 3 years for
hose who underwent a BTS (n  46) (log-rank  0.31)
Fig. 3). Conditional survival analysis of those who patients
ho underwent a RV-PA conduit, survived the periopera-
ive period, and subsequently were discharged after S1P (n 
9) was 96.6% at 1 year and 93.1% at 3 years after discharge
ompared with 85.2% and 74% for those who underwent a
TS (n  41) (log-rank  0.06) (Fig. 4).
Fontan
RV-PA conduit (n  23) p Value
94 (64–159) 0.04
20 (87%) 0.01
53.5 (13–77) 0.89
0 (0%) 1.0*
3 (13%) 1.0*
1 (4%) 1.0*
1 (5%) 0.45*
6 (26.1%) 0.72
10 (0–25) 0.80
35.5 (8.2–109.4) 0.98
6 (2–21) 0.78
21 (10–96) 0.09
2 (0–6) 0.01
9 (5–29) 0.89
nd categorical variables, respectively. p values were obtained from
test (categorical variables). *Fisher exact test.es at
26)
89)
07)
)
)
.5)
17.5)
)
4)
)
)
nuous a
r exactube; ICU  intensive care unit; PA  pulmonary artery; RV-PA  right
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July 1, 2008:52–9 Fontan Outcomes After mBTS or RV to PA ConduitA multivariable model was constructed to test the inde-
endent impact of shunt type at S1P on survival through
ontan completion using perioperative S1P variables found
o be statistically significant in univariate testing. The
erioperative S1P variables that did not reach significance in
nivariate survival analysis were gender, fetal diagnosis,
scending aorta size, and birth weight. Controlling for the
se of peritoneal dialysis and extracorporeal membrane
xygenation after S1P, the presence of hypoplastic left heart
yndrome, and an intact atrial septum before S1P (all
ariables found to be significant in univariate testing), the
se of a RV-PA conduit was not associated with improved
urvival (hazard ratio: 1.2, 95% confidence interval: 0.4 to
.1, p  0.75) (Table 4).
Figure 3 Kaplan-Meier Plot of Freedom From Pulmonary
Artery Intervention After S1P by Type of Shunt
Cumulative survival after S1P by shunt. Abbreviations as in Figure 1.
Figure 4 Kaplan-Meier Plot of Conditional Survival
After Discharge After S1P by Type of Shunt
Survival after S1P discharge by shunt type. Time zero
indicates discharge after S1P. Abbreviations as in Figure 1.iiscussion
e report a single institution’s experience with Fontan
ompletion and overall survival in a cohort of patients who
nderwent S1P with either a modified BTS or RV-PA
onduit concurrently. We show no statistical differences
etween the 2 groups in pre-operative variables or periop-
rative outcomes for those undergoing Fontan completion,
ith the exception of decreased intensive care unit length of
tay for those undergoing a RV-PA conduit. When the
ntire cohort of patients was examined, a trend toward
mproved cumulative survival up to 3 years after S1P for
hose who underwent a RV-PA conduit was demonstrated,
lthough this difference did not reach statistical significance.
dditionally, our survival rate of approximately 75% at 5
ears for the RV-PA conduit is similar to that described by
ano et al. (23) in a recent noncomparative experience.
imilarly, conditional survival analysis of those who patients
ho survived and subsequently were discharged after S1P,
uggests a strong, albeit statistically nonsignificant, trend
oward improved survival for the RV-PA conduit group
hrough the period of Fontan completion. These data
uggest that potential longitudinal survival advantage for the
V-PA conduit might exist after the perioperative S1P
eriod, through the interstage period before BCPA and
ithout decrement through Fontan completion. However,
iven the lack of statistically significant differences in
urvival in univariate or multivariable testing of our data,
ither cumulative or conditional, we must conclude that if
ctual differences exist between the 2 groups, their statistical
emonstration will require greater numbers of patients with
xtended longitudinal follow-up.
These data should encourage the long-term longitudinal
ollow-up of those patients currently enrolled in the Single
entricle Reconstruction Trial sponsored by the Pediatric
eart Network, a randomized prospective study evaluating
ortality in patients undergoing a modified BTS or RV-PA
onduit during S1P for single ventricle physiology.
We examined the influence on survival of the distance
etween home residence and site of S1P and the distance
etween home residence site of interstage follow-up. We
ound a nonstatistically significant trend towards decreased
ndependent Risk Factors at S1Por Death Through Fontan Completion*
Table 4 Independent Risk Factors at S1Pfor Death Through Fontan Completion*
Stage One Palliation Variables
Hazard
Ratio†
95% Confidence
Interval p Value
RV-PA conduit 1.2 0.4–3.1 0.75
Intact atrial septum 1.6 0.6–4.2 0.38
Non-HLHS morphology 3.6 1.3–10.2 0.02
Post-operative peritoneal dialysis 5.6 1.5–21.1 0.01
Post-operative ECMO 5.7 2.0–15.9 0.01
n  80; total number of deaths  22. †Hazard ratios based on a 1 unit increase in the value of
he corresponding covariate.
ECMO  extracorporeal membrane oxygenation; HLHS  hypoplastic left heart syndrome;
V-PA  right ventricle to pulmonary artery.nterstage survival before BCPA, but not in overall survival
t
d
f
f
f
s
t
d
d
a
e
c
A
p
d
e
d
t
i
c
F
o
v
d
s
p
s
p
p
s
a
g
i
c
p
g
t
t
w
i
d
s
o
c
c
t
o
p
m
F
t
s
n
a
h
s
p
c
t
B
i
i
l
d
p
S
n
T
r
t
f
c
l
c
s
t
v
v
c
n
a
n
B
f
t
d
C
O
F
D
i
t
d
l
c
i
p
m
i
p
c
S
58 Scheurer et al. JACC Vol. 52, No. 1, 2008
Fontan Outcomes After mBTS or RV to PA Conduit July 1, 2008:52–9hrough follow-up, in those patients remote in home resi-
ence from the institution of S1P and site of interstage
ollow-up.
Previous investigations by Ghanayem et al. (24) have
ound significant improvement in interstage survival be-
ore BCPA in patients enrolled in an aggressive inter-
tage monitoring and follow-up program. Our institution,
he site of S1P for these patients, does not use interstage
aily home saturation monitoring and weight checks as
escribed by the Wisconsin group. Given the findings, we
re reexamining interstage follow-up for all patients, to
nsure consistency and optimal outcomes.
The hemodynamics of the 2 groups before Fontan
ompletion at our institution were remarkably similar.
lthough they were subjectively graded by echocardiogra-
hy and retrospectively reviewed, the degrees of ventricular
ysfunction and atrioventricular valve regurgitation were
ssentially identical. Similarly, Sano et al. (25) found no
ifference between groups in pre-Fontan ventricular func-
ion by echocardiography in a total of 14 patients undergo-
ng Fontan. Although at least 1 group has reported de-
reased ventricular contractility at the time of pre-operative
ontan catheterization associated with the RV-PA conduit,
ur data revealed no differences in cardiac index or systemic
entricular end-diastolic pressures (26). Thus, ventricular
ysfunction was not a factor found to alter Fontan course or
urvival between the 2 groups.
We found that mean pulmonary artery pressures and
ulmonary vascular resistances between the groups were
imilar at pre-operative catheterization. Although indices of
ulmonary artery size were not serially measured in our
atients over time, other groups have found that, despite a
ignificant incidence of central pulmonary artery hypoplasia
t the insertion of the conduit, distal pulmonary artery
rowth as assessed by the Nakata or McGoon technique was
ncreased with RV-PA conduit (10,27). Similar to other
enters that have reported an increase in the need for
ulmonary artery interventions in the RV-PA conduit
roup before or at the time of BCPA, we found a trend
oward increased need for pulmonary artery intervention in
his group through Fontan completion (5,28).
Interestingly however, the rate of chest tube output, as
ell as the duration of indwelling chest tubes was nearly
dentical between the groups at Fontan completion. These
ata would suggest to us that residual pulmonary artery
tenosis had adequately been addressed either operatively
r by balloon dilation before and at the time of Fontan
ompletion and also suggest that there were no important
linical difference in post-operative Fontan baffle pressures
hat might result from residual pulmonary arterial stenosis
r hypoplasia. Thus, our experience suggests that although
atients who receive a RV-PA conduit at S1P might require
ore total interventions to the pulmonary arteries through
ontan completion, this reintervention rate has not nega-
ively altered perioperative Fontan course. Future sources of
tudy should include evaluations of the need for pulmo- tary artery interventions in the RV-PA conduit group
fter Fontan and the incidence of late pulmonary arterial
ypoplasia.
The operative courses were similar between groups de-
pite the use of aortic cross-clamp in a greater number of
atients in the RV-PA conduit group. The post-operative
ourses were different in several respects. There was a trend
oward increased duration of ventilation in the modified
TS group; however, it did not reach statistical significance
n this study. The intensive care unit length of stay was
ncreased in the modified BTS group; however, the total
ength of hospital stay was similar for both groups. The
isparate nature of these findings can not be readily ex-
lained in our data without further examination.
tudy limitations. This study is limited by its retrospective
ature and the biases inherent in this type of study design.
he patients were not randomized, and there is an under-
epresentation of patients in the RV-PA conduit group. On
he basis of this nonrandom approach, unidentified risk
actors between the groups could significantly impact out-
omes without detection. The cohort is small; thus, only
arge differences in comparisons will be able to be statisti-
ally identified. Multivariable modeling with these relatively
mall numbers of outcomes is subject to overfitting, al-
hough an attempt was made to limit the number of
ariables included for adjustment, including only those
ariables reaching statistical significance (p  0.05).
Given the small difference in survival through Fontan
ompletion that we found between the 2 groups, one would
eed to enroll approximately 125 patients in each group in
randomized prospective trial of comparing the two tech-
iques for this difference to reach statistical significance.
ecause not all patients had all subsequent palliations and
ollow-up at our institution and because one patient has yet
o complete palliation with a Fontan operation, important
ifferences between the groups could fail to be identified.
onclusions
ur data suggest that the pre-operative characteristics at
ontan completion are similar between the 2 groups.
espite similar pre-operative characteristics, including sim-
lar echocardiographic measurements of ventricular func-
ion, the use of a RV-PA conduit at S1P was associated with
ecreased intensive care unit length of stay but not hospital
ength of stay. Follow-up through and shortly after Fontan
ompletion in this cohort suggest nonstatistically significant
mproved survival at the expense of increased need for
ulmonary artery interventions. However, multivariable
odeling did not reveal the use of a RV-PA to be an
ndependent predictor of survival at this follow-up.
This work provides the first description of Fontan com-
letion in 2 groups of patients who have undergone con-
urrently either a modified BTS or RV-PA conduit during
1P. These findings should be verified in a larger cohort
hat has been randomized to either technique at stage one
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hese patients will be required to evaluate pulmonary artery
rowth and the incidences of late ventricular dysfunction
nd arrhythmias.
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